The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy... von Luker, Andrea J, Graham, Laura J, Smith, Jr, Timothy M, Camarena, Carmen, Zellner, Matt P, Gilmer, Jamie-Jean S, Damle, Sheela R, Conrad, Daniel H, Bear, Harry D, Martin, Rebecca K

Volltext